ObsEva (NASDAQ:OBSV) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued to investors on Tuesday. The brokerage issued a hold rating on the stock.

ObsEva Stock Performance

The business has a fifty day moving average price of $0.01. The firm has a market capitalization of $7.94 million, a PE ratio of -0.11 and a beta of 0.68. ObsEva has a twelve month low of $0.08 and a twelve month high of $2.14.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.